Terns pharmaceuticals inc.

Major-Pharmaceuticals

TERN


Executive/
Director

Price

  • Last Close
  • $ 6.92
    $ +0.35 5.25 %
    Dec 10, 2024
  • 52-Week High/Low
  • $8.28 - $3.37
  • YTD
  • 6.6%

  • Trading Volume
  • 74,423
  • Market Cap Full
  • $ 427.6M
  • Shares Outstanding
  • 61.8M
    Nov 3, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - -53.9% 16.3% 1.1%
Q2 - - - - - - -44.3% -14.3% -26.1% -6.5%
Q3 - - - - - - -15% 137.5% -42.5% -
Q4 - - - - - - -39.7% 72.8% 32.2% -
J F M A M J J A S O N D
2024 -20.2% 41.3% -10.4% 1.2% - - - - - - - -
2023 -10.9% 11.7% 16.9% 10.2% -18.7% -17.5% -17.5% -27% -4.6% 4.6% -15.4% 45.8%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%62%-36%7%

Earnings

2021 2022 2023
Q1 -0.88 -0.55 -0.31
Q2 -0.43 -0.55 -0.25
Q3 -0.47 -0.44 -0.42
Q4 -0.43 -0.13 -
A -2.2 -1.7 -0.98

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 25.3 56.7
Jun 25.1 25.3 56.7
Sep 25.1 25.4 61.1
Dec 25.3 37.6 61.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - 1 - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 31 - -12.3 70 -
Equity multiplier - - - 0.1 -